Amritha Jaishankar

Executive Director, Cell and Gene Therapy Center, IQVIA

Role: Scientist

Sites: CDL-Oxford, CDL-Toronto, CDL-Vancouver, CDL-Wisconsin

Stream: Advanced Therapies

Dr. Amritha Jaishankar serves as the Executive Director of IQVIA’s Cell and Gene Therapy Center. The Center is focused on accelerating preclinical/clinical development and commercialization of cell and gene therapies for companies and research institutions. She brings over 18 years of stem cell expertise in federal, university, and industry settings. Dr. Jaishankar’s leadership and unique approach to global collaborations and partnerships have been integral to advancing research, development, and commercialization of promising cell therapies and regenerative medicine technologies.

She previously served as the Executive Director of the Maryland Stem Cell Research Fund (MSCRF) where her leadership, passion, and knowledge were instrumental in establishing her organization as Maryland’s leading organization to identify, invest in and foster cell-based technologies. She led MSCRF to its highest visibility and budget in over a decade and developed Maryland’s first cell therapy manufacturing assistance program. Leading its accelerating cures initiative since 2016, Dr. Jaishankar’s work supported over 200 projects, moved over 104 technologies towards commercialization, and helped create and grow numerous companies. Her measurable impact, roles on numerous boards and committees, and experience as a stem cell scientist have made Dr. Jaishankar a proven leader and champion for stem cell research and commercialization.